MGPI · Insider Trading
MGP Ingredients Inc
Every open-market purchase and sale reported by MGPI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Martin Roper | Director | A | +2,924 | +$38.74K |
| 2026-09-18 | Leslie Lux | 10%+ Owner | Sell | −55,462 | −$798.80K |
| 2026-08-24 | Paul S. Lux | 10%+ Owner | Sell | −33,000 | −$586.22K |
| 2026-08-06 | Julie Maria Francis | President & CEO | F | −1,994 | −$34.12K |
| 2026-08-06 | Julie Maria Francis | President & CEO | F | −1,994 | −$34.12K |
| 2026-07-02 | Martin Roper | Director | A | +2,232 | +$38.75K |
| 2026-05-28 | Caroline Lux Kaplan | 10%+ Owner | Sell | −60,000 | −$1.08M |
| 2026-05-15 | Gerardo I Lopez | Director | A | +5,801 | — |
| 2026-05-15 | Martin Roper | Director | A | +5,801 | — |
| 2026-05-15 | Thomas A Gerke | Director | A | +5,801 | — |
| 2026-05-15 | Jennifer Elaine Lowry | Director | A | +5,801 | — |
| 2026-05-15 | Mercedes Romero | Director | A | +5,801 | — |
| 2026-05-15 | Todd B. Siwak | Director | A | +5,801 | — |
| 2026-05-15 | Lori L.S. Mingus | Director | A | +5,801 | — |
| 2026-05-01 | Julie Maria Francis | President & CEO | A | — | — |
| 2026-04-02 | Martin Roper | Director | A | +2,112 | +$38.73K |
| 2026-03-06 | Julie Maria Francis | President & CEO | A | +30,569 | — |
| 2026-03-06 | Kathleen Susan Molamphy | Chief Legal and HR Officer | A | +15,816 | — |
| 2026-03-06 | Brandon Gall | CFO | A | +21,979 | — |
| 2026-02-25 | Kathleen Susan Molamphy | Chief Legal and HR Officer | A | +5,609 | — |
| 2026-02-25 | Julie Maria Francis | President & CEO | A | +58,674 | — |
| 2026-02-25 | Brandon Gall | CFO | A | +13,687 | — |
| 2026-02-20 | Brandon Gall | CFO | F | −598 | −$15.51K |
| 2026-02-20 | Amel Pasagic | Chief Commercial Officer | F | −346 | −$8.97K |
| 2026-02-20 | Erika Lapish | CHRO | F | −241 | −$6.25K |
| 2026-02-18 | Erika Lapish | CHRO | F | −1,765 | −$45.43K |
| 2026-02-18 | Amel Pasagic | Chief Commercial Officer | F | −2,271 | −$58.46K |
| 2026-02-18 | Brandon Gall | CFO | F | −3,996 | −$102.86K |
| 2026-01-02 | Martin Roper | Director | A | +1,594 | +$38.73K |
| 2025-12-10 | Karen Seaberg | Director | Sell | −304,535 | −$7.51M |
| 2025-11-20 | Caroline Lux Kaplan | 10%+ Owner | Sell | −60,000 | −$1.41M |
| 2025-10-03 | Martin Roper | Director | A | +1,579 | +$38.75K |
| 2025-08-21 | Karen Seaberg | Director | J | — | — |
| 2025-08-05 | Julie Maria Francis | President & CEO | A | +20,587 | — |
| 2025-07-03 | Martin Roper | Director | A | +724 | +$23.80K |
| 2025-05-22 | Thomas A Gerke | Director | A | +3,281 | — |
| 2025-05-22 | Martin Roper | Director | A | +3,281 | — |
| 2025-05-22 | Gerardo I Lopez | Director | A | +3,281 | — |
| 2025-05-22 | Todd B. Siwak | Director | A | +3,281 | — |
| 2025-05-22 | Kevin Rauckman | Director | A | +3,281 | — |
| 2025-05-22 | Jennifer Elaine Lowry | Director | A | +6,093 | — |
| 2025-05-15 | Donn S. Lux | Director | Sell | −100,000 | −$3.27M |
| 2025-05-13 | Caroline Lux Kaplan | 10%+ Owner | Sell | −46,231 | −$1.54M |
| 2025-05-08 | Martin Roper | Director | Buy | +15,000 | +$496.50K |
| 2025-05-02 | Karen Seaberg | Director | Sell | −12,201 | −$374.92K |
| 2025-05-02 | Lori L.S. Mingus | Director | Sell | −335 | −$10.75K |
| 2025-04-16 | Gerardo I Lopez | Director | A | +3,180 | — |
| 2025-04-16 | Martin Roper | Director | A | +3,180 | — |
| 2025-04-03 | Thomas A Gerke | Director | A | +751 | +$21.25K |
| 2025-04-03 | Preet H. Michelson | Director | A | +662 | +$18.73K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Donn S. Lux | Director | 2,438,264 | $39.52M |
| Paul S. Lux | 10%+ Owner | 550,458 | $8.92M |
| Caroline Lux Kaplan | 10%+ Owner | 470,958 | $7.63M |
| Karen Seaberg | Director | 114,279 | $1.85M |
| Julie Maria Francis | President & CEO | 107,836 | $1.75M |
| Brandon Gall | CFO | 87,278 | $1.41M |
| Martin Roper | Director | 38,427 | $622.90K |
| Kathleen Susan Molamphy | Chief Legal and HR Officer | 28,738 | $465.84K |
| Thomas A Gerke | Director | 17,118 | $277.48K |
| Todd B. Siwak | Director | 13,086 | $212.12K |
| Gerardo I Lopez | Director | 12,262 | $198.77K |
| Jennifer Elaine Lowry | Director | 11,894 | $192.80K |
| Amel Pasagic | Chief Commercial Officer | 10,487 | $169.99K |
| Erika Lapish | CHRO | 9,671 | $156.77K |
| Kevin Rauckman | Director | 7,518 | $121.87K |
| Lori L.S. Mingus | Director | 6,220 | $100.83K |
| Mercedes Romero | Director | 5,801 | $94.03K |
| Preet H. Michelson | Director | 5,610 | $90.94K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MGPI quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.